Achieve Life To Advance Cytisinicline Into Phase 3 Study For Vaping Cessation In Q3, 2025
Achieve Life Sciences Announces Outcome of End-of-Phase 2 Meeting With FDA
Express News | Achieve Life Sciences Inc - Expects to File Nda for Smoking Cessation in Q2 2025
Express News | Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting With FDA
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Stock_Drift : Mmmmm, nice.
Bigmoney Dreamer : Bidders overtaking askers need to break 6.00$ otherwise very very long hold ..anyway buy signal in quarterly may can break over within next 3-6 months